openPR Logo
Press release

Global Myelodysplastic Syndrome (MDS) Treatment Market Widespread Research and Fundamental study to 2025 Appraised By Global Players Novartis AG, Celgene Corporation, Otsuka Pharmaceutical Co., Ltd., Dr Reddys Laboratories Limited, Pharmascience Inc.

02-21-2019 02:02 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Myelodysplastic Syndrome (MDS) Treatment Market

Global Myelodysplastic Syndrome (MDS) Treatment Market

Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around 30% of the patients, known as Acute Myeloid Leukemia (AML). MDS is most commonly found in aging population and remains an incurable disease in majority of patients. According to the American Cancer Society, over 13,000 new cases of MDS occur in the U.S. every year. This is expected to drive the growth of myelodysplastic syndrome treatment market. Hypomethylating drugs such as azacitidine and decitabine help stimulate blood cells to mature and improve blood cell production in MDS.

For In depth Information Get Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/775

Rising Implications Associated With Myelodysplastic Syndrome Are Expected To Affect The Myelodysplastic Syndrome Treatment Market:

According to the American Cancer Society, the incidence rate for myelodysplastic syndrome is 13,000 new cases each year which happens at a rate of 4.8 cases per 100,000 people. This trend is heavily affected or rather influenced by the average age of the population which, according to the World Health Organization (WHO), is increasing and is expected to double from 12% to 22% between 2015 and 2050. Furthermore, according to the American Society of Clinical Oncology (ASCO), age plays an important role in the occurrence of myelodysplastic syndrome as most of the people diagnosed with the disease are of age 65 and older. These factors are expected to boost the myelodysplastic syndrome treatment.

Market Dynamics

According to the American Society of Hematology, in 2016, prevalence of MDS ranged from 0.22-13.2 per 100,000, on all age categories and ethnicities globally. Increasing public awareness about the disease and introduction of new treatment for MDS will drive the growth of the market. Furthermore, growing aging population is analyzed to be a major factor propelling the growth of myelodysplastic syndrome treatment market. According to NCBI, 2012, the incidence of MDS increases significantly with age and the disease is most prevalent in males. Besides, companies such as Celgene and Novartis, who offer innovative brands in this market would be able to combat the loss of share, post patent expiry through their pipeline molecules expected to be launched during the forecast period.

Market Taxonomy

This report segments the global myelodysplastic syndrome treatment market on the basis of drugs. On the basis of drugs, the global Myelodysplastic syndrome treatment market is classified into Azacitidine, Lenalidomide, Decitabine, and Deferasirox. For comprehensive understanding of market dynamics, the global myelodysplastic syndrome treatment market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key Players:

Key companies covered as a part of this study include Novartis AG, Celgene Corporation, Otsuka Pharmaceutical Co., Ltd., Sandoz Inc., Dr Reddys Laboratories Limited, Pharmascience Inc., Accord Healthcare Ltd, Mylan N.V.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/775

Detailed Segmentation:

Global Myelodysplastic syndrome treatment market, By Drug:
Azacitidine
Lenalidomide
Decitabine
Deferasirox

Global Myelodysplastic syndrome treatment market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Myelodysplastic Syndrome (MDS) Treatment Market Widespread Research and Fundamental study to 2025 Appraised By Global Players Novartis AG, Celgene Corporation, Otsuka Pharmaceutical Co., Ltd., Dr Reddys Laboratories Limited, Pharmascience Inc. here

News-ID: 1607490 • Views: 505

More Releases from Coherent Market Insights

Ophthalmic Devices Market See Incredible Growth 2022-2028 | Carl Zeiss Meditec G …
The Coherent Market Insights has announced the release of a new report titled Ophthalmic Devices Market 2022, which provides regional and global market data that is expected to grow in value between 2022 and 2028. The comprehensive study of the global Ophthalmic Devices Market provides critical insights into the industry's changing dynamics, value chain analysis, prominent investment pockets, competitive scenarios, geographical landscape, and key segments. It also provides a thorough
Air Abrasion Unit Market Expected to Expand at a Steady 2022-2028 | Danville, Ve …
The Coherent Market Insights has announced the release of a new report titled Air Abrasion Unit Market 2022, which provides regional and global market data that is expected to grow in value between 2022 and 2028. The comprehensive study of the global Air Abrasion Unit Market provides critical insights into the industry's changing dynamics, value chain analysis, prominent investment pockets, competitive scenarios, geographical landscape, and key segments. It also provides
Body Contouring Devices Market Future Business Opportunities 2022-2028 | Cynosur …
The Coherent Market Insights has announced the release of a new report titled Body Contouring Devices Market 2022, which provides regional and global market data that is expected to grow in value between 2022 and 2028. The comprehensive study of the global Body Contouring Devices Market provides critical insights into the industry's changing dynamics, value chain analysis, prominent investment pockets, competitive scenarios, geographical landscape, and key segments. It also provides
Special Need Strollers Market Huge Growth in Future Scope 2022-2028
The Coherent Market Insights has announced the release of a new report titled Special Need Strollers Market 2022, which provides regional and global market data that is expected to grow in value between 2022 and 2028. The comprehensive study of the global Special Need Strollers Market provides critical insights into the industry's changing dynamics, value chain analysis, prominent investment pockets, competitive scenarios, geographical landscape, and key segments. It also provides

All 5 Releases


More Releases for MDS

Healthcare M2M Market to See Huge Growth by 2025 | Athenahealth, McKesson, Amazi …
The Latest research study released by HTF MI “Global Healthcare M2M Market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research
Myeloidysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
Myeloidysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in blood-forming cells in the bone marrow. It is a rare blood cancer and can be mild, moderate or severe, in terms of severity. Download the sample report @ https://www.pharmaproff.com/request-sample/1162 This syndrome can be classified into three main types: MDS with single lineage dysplasia wherein a single type of blood cell appears abnormal; multilineage
Top Scenario: Healthcare CRM Market By Key Players: Allscripts, Cerner, e-MDs, C …
Qyresearchreports include new market research report Healthcare CRM to its huge collection of research reports. Healthcare CRM, also known as Healthcare Relationship Management, is a broadly used term for a Customer relationship management system In 2017, the global Healthcare CRM market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global
Myelodysplastic Syndrome (MDS) Treatment Market Industry Forecast till 2025
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more
Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Trends, Analysis …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “2018-2025 Report on Global and United States Myelodysplastic Syndrome (MDS) Therapeutics Market Status and Forecast, by Players, Types and Applications” which provides an outlook of current market growth as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR near XX% during 2018-2025. The report studies myelodysplastic syndrome therapeutics in global market,
Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Insights 2025
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around